NCT01249261View on ClinicalTrials.gov

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Postmenopausal Women With Osteoporosis
Interventions
DRUG

Risedronate

5 mg/day

DRUG

Placebo/Risedronate

placebo years 1-5 followed by 5 mg risedronate years 6 \& 7 and no drug year 8

Trial Locations (13)

2139

Investigational Site, Concord

3052

Investigational Site, Parkville

28040

Investigational Site, Madrid

B-9000

Investigational Site, De Pintelaan 185

DK-2650

Investigational Site, Hvidovre

SF-90 100

Investigational Site, Oulu

I-53100

Investigational Site, Siena

PL 03-0335

Investigational Site, Warsaw

PL-02315

Investigational Site, Warsaw

PL-04-736

Investigational Site, Warsaw

PL00-909

Investigational Site, Warsaw

08907

Investigational Site, Barcelona

S-411 32

Investigational Site, Gothenburg

Sponsors

Lead Sponsor

Warner Chilcott
All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT01249261 - Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover | Biotech Hunter | Biotech Hunter